500 kcal/day
That is the daily calorie intake deficit the insuarance companies want you to document properly
150 minutes/day
That is the weekly activities/walking minutes the insuarance companies want you to document properly
That is the daily calorie intake deficit the insuarance companies want you to document properly
That is the weekly activities/walking minutes the insuarance companies want you to document properly
Whether you're being evaluated for semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound), insurance carriers want to ensure that non-pharmaceutical interventions have been attempted first. Here's why documentation is non-negotiable:
Insurers need clear, time-stamped records of lifestyle interventions before approving medication. Without documentation, your request will likely be denied.
Lifestyle logs help demonstrate that your condition is not being managed by behavioral changes alone, making the case for medication support stronger.
Your primary care physician or specialist will need to submit proof of failed lifestyle interventions as part of the insurance submission process.
To streamline this process and meet insurance requirements with ease, the Semaglutide App for GLP-1 offers everything you need to properly document your journey.
Quickly track meals and monitor caloric intake to stay consistent with a 500-calorie deficit goal.
Syncs with Apple Health to pull in walking and movement data effortlessly, helping you hit that 150-minute weekly target.
download now
Creates clean, exportable reports you can send directly to your primary care provider or insurance company to support prior authorization requests.
download now
Tailored to those pursuing semaglutide/tirzepatide therapy, with reminders, education, and updates relevant to your medication and insurance path
download now
Insurance providers now require "proof of lifestyle modification"—such as a 500-calorie daily deficit and 150 minutes of physical activity per week—as a pre-requisite for prior authorization. This documentation shows that you have attempted non-medication-based methods before starting a GLP-1 drug.
Most GLP-1 medications including:
- Ozempic (semaglutide)
- Wegovy (semaglutide for weight loss)
- Mounjaro*(tirzepatide)
- Zepbound (tirzepatide for weight loss)
These are prescribed for obesity, type 2 diabetes, cardiovascular risk reduction, and sleep apnea—but insurance often requires proof that you tried to manage these conditions through lifestyle changes first.
Daily calorie intake showing a ~500-calorie deficit
- Weekly physical activity, totaling at least 150 minutes of moderate-intensity movement
- Optionally: weight, mood, meals, and progress photos
Most insurance companies require at least 90 days of documented lifestyle change before approving medication. Your healthcare provider can confirm the specific duration based on your insurance plan.
The **Semaglutide App** is the recommended tool. It allows you to:
- Log meals to monitor caloric intake
- Automatically pull steps from Apple Health or your phone’s pedometer
- Generate reports that can be sent directly to your doctor or insurance provider
While documentation strengthens your case, coverage is still dependent on your insurance provider’s criteria. Factors may include BMI, medical history, and other conditions. However, Lack of documentation is one of the top reasons for denial, so it’s critical to track properly.
Unfortunately, insurance won’t accept verbal confirmation or memory-based tracking. You’ll need to begin consistent, trackable documentation going forward—even if you’ve already made progress.
And use the **Semaglutide App** to track, organize, and generate the exact proof insurers need. You’re not just showing your effort—you’re unlocking access to treatment that could change your life.
